select trial glp 1 Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the From diabetes drugs... to weight

European Journal of Clinical Pharmacology, 1992

It is delivered subcutaneously once daily and measured in micrograms

These nanoformulations improve aqueous solubility, protect labile molecules from degradation, prolong systemic circulation, and enable passive or active tumor targeting via the enhanced permeability and retention (EPR) effect or ligand-mediated delivery (152)

The weight loss achieved varies by agent and dosetypically modest with standard diabetes doses but potentially greater (510% or more) with higher doses such as semaglutide 2.4 mg

Second, the herbal ingredients commonly found in GLP-1 patches have not been proven effective for weight loss when delivered through the skin